Page last updated: 2024-08-07 14:57:49
Env polyprotein
[no definition available]
Synonyms
Research
Bioassay Publications (3)
| Timeframe | Studies on this Protein(%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Compounds (5)
Drugs with Inhibition Measurements
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|
| nbd 556 | Human immunodeficiency virus 1 | IC50 | 0.6100 | 1 | 1 |
Drugs with Activation Measurements
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|
| oleanolic acid | Human immunodeficiency virus 1 | EC50 | 100.0000 | 1 | 1 |
| ursolic acid | Human immunodeficiency virus 1 | EC50 | 100.0000 | 1 | 1 |
| betulinic acid | Human immunodeficiency virus 1 | EC50 | 100.0000 | 1 | 1 |
| enfuvirtide | Human immunodeficiency virus 1 | EC50 | 0.1887 | 3 | 3 |
| enfuvirtide | Human immunodeficiency virus 1 | Kd | 0.1820 | 1 | 1 |
Glycosylated enfuvirtide: a long-lasting glycopeptide with potent anti-HIV activity.Journal of medicinal chemistry, , Feb-12, Volume: 58, Issue:3, 2015
Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: a promising strategy for discovering new antiviral therapeutics.Journal of medicinal chemistry, , Sep-11, Volume: 57, Issue:17, 2014